CURRICULUM VITAE PERSONAL INFORMATION NAME KHALIL GHASEMI FALAVARJANI ADDRESS Eye Department, Rassoul Akram Hospital, Sattarkhan-Niayesh St. POBox:1445613131 Tehran, Iran Phone: +98 9121725850, +98 21 66509162 Fax: +98 21 66509162 Email: drghasemi@yahoo.com NATIONALITY Iranian LANGUAGE Farsi, English EDUCATIONS International Retina Fellowship UCLA/Doheny Eye Institute 2015-16 Surgical and Medical retina Iran University of Medical Sciences (IUMS) Fellowship Tehran, Iran 2008-09 Ophthalmic Oncology IUMS, Tehran, Iran 2009-10 Iranian Board Certification IUMS 2007 in Ophthalmology and Tehran, Iran Ophthalmic Surgery with "A" score. Ophthalmology Residency Rassoul Akram General Hospital 2003-2007 IUMS, Tehran, Iran

MD Grade "A" graduation from 1999 Kermanshah University of Medical Sciences Internship Rotational courses at Kermanshah 1997-1999 University hospitals, Kermanshah, Iran Student- and Externship Rotational courses in different wards 1995-1997 at Kermanshah university hospital. Basic Sciences Kermanshah Medical School 1992-1995

POSITIONS Editor In Chief Journal of Current Ophthalmology (Iranian Journal of Ophthalmology) 2015-2016 Director Eye Department, Rassoul Hospital, IUMS 2011- 2015 Dean CME office, IUMS 2010 Member Iran National Ophthalmology Board Examination 2015 Member Iran National Ophthalmology Review Board 2015 Member Iran Supreme Medical Council 2014-2015 (Ophthalmology committee) Editorial Board Middle East African Journal of Ophthalmology (MEAJO) 2012-14 Editorial Board, Section Editor Journal of Ophthalmology and Vision Research 2009-cont` Editorial Board Iranian Journal of Ophthalmology 2009-cont` Editorial Board Journal of Laser in Medicine 2009-2011 Member IUMS Eye Research Center Supreme Council 2015 Scientific Board Annual Meeting of Iranian Society of Ophthalmology 2010-cont` Scientific Board First Iranian Vision Research Seminar 2010 Scientific Board 19th Farabi Annual Meeting 2013 Scientific Board Annual Meeting, Eye Research Center, IUMS 2007-cont` International Committee Iranian Society of Ophthalmology 2009-cont` Director 4th Annual Ophthalmology Congress, Eye Department, IUMS 2010

Scientific Reviewer MEAJO 2013-cont` Scientific Reviewer International Journal of Ophthalmology 2013-cont` Expert Board International Journal of Ophthalmology 2014 Scientific Reviewer Cutaneous and Ocular Toxicicology 2015 Scientific Reviewer American Journal of Ophthalmology 2011-Cont` Scientific Reviewer Journal of Research in Medical Sciences 2012 Scientific Reviewer Journal of Ophthalmology and Vision Research 2009-cont` Scientific Reviewer Journal of Cataract and Refractive Surgery 2008-cont` Scientific Reviewer Journal of Current Diabetes Research 2013 Scientific Reviewer Ophthalmic Plastic and Reconstructive Surgery 2014 Scientific Reviewer Saudi Journal of Ophthalmology 2014-cont` Scientific Reviewer Journal of Expert Opinion on Drug Delivery 2014 Scientific Reviewer Journal of Acta Ophthalmology 2010 Scientific Reviewer Indian Journal of Ophthalmology 2008-cont` Scientific Reviewer Iranian Journal of Ophthalmology 2008-cont` Scientific Editor Cheshmkhaneh periodical eye journal 2007-2014 Ophthalmic Paraclinic Director Rassoul Akram University hospital 2007-2011 Tehran, Iran Assistant Director of Research Eye Research Center, IUMS 2007-2009

HONORS Distinct Young Researcher Award, Avicenna Medical Festival 2013 Tehran University of Medical Sciences (TUMS), Iran Distinct Researcher Award, Razi International Medical Festival 2012 Iran Health Ministry, Tehran Distinct Young Researcher Award, Farabi Eye Festival, TUMS 2010

Sicca Research Award, Iranian Society of Ophthalmology 2010 Best Researcher, IUMS 2009 Ranked 2nd in Iranian Ophthalmology Board examination 2007 Best Resident, IUMS 2007 Ranked 2nd in pre-internship general examination 1997 Ranked 3rd in medical basic science general examination 1994

WORKING EXPERIENCES IUMS Associate Professor of Ophthalmology, 2014-cont` Retina division, Rassoul Akram Hospital, Tehran, Iran IUMS Assistant Professor of Ophthalmology, 2009-2014 Retina division, Rassoul Akram Hospital, Tehran, Iran TUMS Assistant Professor of Ophthalmology, 2013 Retina division, Farabi Eye Hospital, Tehran, Iran IUMS Assistant professor of ophthalmology, 2011-2012 Ophthalmic Oncology Unit, Rassoul Akram Hospital, Tehran, Iran IUMS Assistant professor of ophthalmology, 2007-2008 General Ophthalmology, Rassoul Akram Hospital, Tehran, Iran Governmental Health Center, Isfahan, General Practitioner 2001-2003 Iran Iran Health Ministry, Tehran, Iran General Practitioner (conscription) 1999-2001

RESEARCHES AND PUBLICATIONS

A. English publications

1. Falavarjani KG, Pourhabibi A, Abri Aghdam K, et al. Detemination of the toxicity of

intravitreal minocycline. Cutaneous and Ocular Toxicicology (in press) 2. Falavarjani KG, Golabi S, Hadavandkhani A. Effect of Intravitreal Injection of

Methotrexate on Human Corneal Endothelial Cells. Cornea (in Press)

3. Naseripour M, Falavarjani KG, Sedaghat A, et al. Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. JOVR (in press)

4. Naseripour M, Ghasempour A, Falavarjani KG, et al. Perfluorocarbon liquid migration into the subarachnoid space in a patient with morning glory syndrome. J Curr Op- hthalmol 2015;27:60-2.

5. Yazdi MH, Faramarzi MA, Nikfar S, Falavarjani KG, Abdollahi M. Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration. Expert Opin Biol Ther 2015; 15(9):1349-1358 [Medline]

6. Falavarjani KG, Modarres M, Hadavandkhani A, et al. Intrasilicone oil injection of

methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy. Eye 2015;29(9):1199-203. [Medline]

7. Falavarjani KG, Khadamy J, Karimi N, et al. Posterior sub-tenon’s bevacizumab injection in diabetic macular edema; a pilot study. Saudi J Ophthalmology 2015;29 (4):270-273. [Medline]

8. Falavarjani KG, Khadamy J, Karimi N, et al. Optical Coherence Tomography Grid decentration and Its Effect on Macular Thickness Measurements. Iran J Ophthalmol 2014, 26(3):155-9.

9. Falavarjani KG, Alemzadeh SA, Modarres M, et al. Scleral Buckling Surgery for Rhegmatogenous Retinal Detachment with Subretinal Proliferation. Eye 2015: 29; 509–514. [Medline]

10. Falavarjani KG, Khadamy J, Safi H, et al. Effect of grid decentration on macular thickness measurements in normal subjects and patients with diabetic macular edema. Eur J Ophthalmol 2015;25(3):218-21. [Medline]

11. Hashemi S, Faramarzi MA, Ghasemi Falavarjani K, Abdollahi M. Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia. Expert Opin Biol Ther 2014;14(12):1837-48. [Medline]

12. Falavarjani KG, AghaMirsalim MR, Modarres M, et al. Endophthalmitis after

resident-performed intravitreal bevacizumab injection. Canadian J Ophthalmology 2015;50:33-36. [Medline]

13. Falavarjani KG, Khoshamadi A, Nilforushan N. Peripapillary nerve fiber layer thickness changes after macular photocoagulation for clinically significant diabetic macular edema. Saudi J Ophthalmology 2015; 29: 67-70. [Pubmed]

14. Falavarjani KG, Modarres M. Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment. Eye 2014;28(12):1525-6. [Medline]

15. Nazari Khanamiri H, Falavarjani KG, et al. Complement Factor H Y402H and LOC387715 A69S Polymorphisms in Association with Age-Related Macular Degeneration in Iran. JOVR 2014; 9 (2):181-187. [Pubmed]

16. Faghihi H, Ghassemi F, Falavarjani KG, et al. Spontaneous closure of traumatic macular holes. Canadian J Ophthalmology 2014;49(4):395-8. [Medline]

17. Falavarjani KG, Nguyen QD. Reply to Dr Grzybowski. Eye 2014;28(4):501. [Medline]

18. Falavarjani KG, Hashemi M, Modarres M, Khani AH. Intra-silicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy. Eye 2014;28(5):576-80. [Medline]

19. Modarres M, Rezanejad A, Falavarjani KG. Recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection. Indian J Ophthalmol 2014;62(6):731-3. [Medline]

20. Zhang Z, Liu H, Hernandez-Da mota SE, Romano MR, Falavarjani KG, Ahmadie H, Xu X, Liu K. Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta analysis of randomized controlled trials. Am J Ophthalmol 2013;156:106-115. [Medline]

21. Eshraghi B, Masoomian B, Izadi A, Abedinifar Z, Falavarjani KG. Conjunctival bacterial flora and its changes after successful dacryocystorhinostomy. Ophthalmic Plastic Reconstruct surgery 2014; 30: 44-46. [Medline]

22. Hashemi M, Falavarjani KG, et al. Anterior segment study with the Pentacam Scheimpflug camera in refractive surgery candidates. Middle East Afr J Ophthalmol 2013;20:212-6. [Pubmed]

23. Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti- VEGF agents; a review of literature. Eye (London). 2013;27:787-794. [Medline]

24. Falavarjani KG, Hashemi M, et al. Vitrectomy for posterior segment intraocular

foreign bodies, visual and anatomical outcomes. Middle East Afr J Ophthalmol 2013;20:244-247. [Pubmed]

25. Falavarjani KG. Proliferative Vitreoretinopathy and Genetic Profile. JOVR.

2013;8:92-3. [Pubmed]

26. Parvaresh MM, Falavarjani KG, et al. Transscleral diode laser retinal photocoagulation for the treatment of type one prethreshold retinopathy of prematurity in zone 2. JOVR. 2013; 8 (4): 298-302. [Pubmed]

27. Parvaresh MM, Falavarjani KG. Sympathetic ophthalmia after sclera buckling surgery. Retinal cases and brief reports 2013; 7(4):331-333. [Pubmed]

28. Aghai GH, Vazirnia M, Pourmatin R, Falavarjani KG. Effects of local anesthesia with bupivacaine plus epinephrine on blepharoptosis and levator palpebrae muscle function. Ophthalmic Plastic Reconstruct surgery. 2013;29:198-200. [Medline]

29. Josaghani M, Nazari H, Falavarjani KG, et al. Effect of Homatropine eye drops on pain after photorefractive keratectomy; a pilot study. Saudi J Ophalmol 2013; 27:83–85. [Scopus]

30. Fesharaki H, Kianersi F, Riazi H, Mehrnia A, Naderian G, Modarres M, Falavarjani KG. The effect of posterior versus anterior subtenon injection of triamcinolone on intraocular pressure in eyes with retinal vein occlusion. Iranian Journal of Ophthalmology 2012;24(4):25-30. [Scopus]

31. Falavarjani KG, Nekoozadeh S, Modarres M, et al. Isolates and Antibiotic Resistance

of Culture-Proven Endophthalmitis Cases Presented to a Referral Center in Tehran. Middle East Afr J Ophthalmol 2012;19:361-3. [Pubmed]

32. Hashemi M, Miraftabi A, Nilforushan N, Falavarjani KG, et al. Comparison of the Efficacy and Tolerability of Xalatan® and Xalabiost (Generic Latanoprost) in Adults with Open-Angle Glaucoma or Ocular Hypertension: A Two-Center, Randomized, Crossover Trial. Iranian Journal of Ophthalmology 2012;24(3):11-18. [Scopus]

33. Falavarjani KG, Parvaresh MM, Modarres M, et al. Intravitreal Bevacizumab for

Pseudophakic Cystoid Macular Edema; a Systematic Review. J Ophthalmic Vis Res 2012; 7(3): 235-239. [Pubmed]

34. Falavarjani KG, Modarres M, Hashemi M, et al. Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center. Retina 2013;33(5):971-4. [Medline]

35. Falavarjani KG, Parvaresh MM, Shahraki K, et al. Central retinal artery occlusion in

Crohn disease. JAAPOS 2012; 16:392-3. [Medline]

36. Modarres M, Nazari H, Kanavi MR, Nikghbalil A, Falavarjani KG, Aghdam KA. Determination of Safety of Escalating Doses of Intravitreal Erythropoietin in Rabbit Eyes. Iranian Journal of Ophthalmology 2012;24(2):26-32. [Scopus]

37. Falavarjani KG, Hashemi M, Fazel AJ, et al. Pars Plana Vitrectomy and Intravitreal Phacoemulsification for Dropped Nuclei. J Ophthalmic Vis Res 2012; 7 (2): 125-129. [Pubmed]

38. Falavarjani KG, Sanjari MS. Detection of optic disc oedema using optical coherence tomography. Br J Ophthalmol 2012;96:1355-1357. [Medline]

39. Rohani M, Langroodi AS, Ghourchian S, Falavarjani KG, Soudi R, Shahidi G. Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease. Neurol Sci. 2013; 34:689-93. [Medline]

40. Soleimani M, Falavarjani KG, Foroutan AR. Pupil size and LASIK. Ophthalmology. 2012;119(4):882-3. [Medline]

41. Falavarjani KG, Modarres M. Heavy Silicone Oil Removal Without Suction Pump: A Surgical Technique. Retina 2011;31:1961-2. [Medline]

42. Aghai GH, Fereidounian NA, Khalatbari M, Hejazian E, Falavarjani KG. Orbitofrontal cholesterol granuloma; Report of two cases and review of literature. Iranian J Ophthalmol 2011;23:60-64. [Scopus]

43. Falavarjani KG, Modarres M. Transscleral Diffusion of Triamcinolone. Ophthalmology 2011;7:1487. [Medline]

44. Falavarjani KG, Modarres M. Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders. J Ophthalmic Vis Res 2011;6:76-7. [Pubmed]

45. Modarres M, Falavarjani KG, Nazari H, et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2011;95:992-995. [Medline]

46. Falavarjani KG, Mohammadreza H, Hejazi SM, Naseripour M. A Modified Semiautomatic Method for Measurement of Hyperfluorescence Area in Fluorescein Angiography. Iranian J Ophthalmol 2010;22(4):73-79. [Scopus]

47. Falavarjani KG. CONSULTATION SECTION. J Cataract Refract Surg

2010;36:1443. [Medline]

48. Foroutan A, Beigzadeh F, Bakhtiari P, Joshaghani M, Falavarjani KG, Afshar AE,

Foroutan P. Perilimbal Bevacizumab Injection for Interface Neovascularization After Deep Anterior Lamellar Keratoplasty. Cornea 2010;29:1268-1272. [Medline]

49. Nazari H, Parvaresh MM, Modarres M, Falavarjani KG. Intravitreal bevacizumab in

combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 2010; 248:1713-1718. [Medline]

50. Falavarjani KG, Naseripour M. New Hope for Retinoblastoma Patients. J

Ophthalmic Vis Res 2010;5:213-14. [Pubmed] 51. Falavarjani KG, Modarres M. Perioperative Use of Bevacizumab in Vitrectomy for

Proliferative Diabetic Retinopathy: A Literature review. Iranian J Ophthalmol 2010;22(4):5-12. [Scopus]

52. Nilforushan N, Yadgari M, Falavarjani KG, Afshar AE. Evaluation of Subconjunctival Oculusgen Implantation as an Adjunct to Trabeculectomy. Iranian J Ophthalmol 2010;22(4):55-62. [Scopus]

53. Falavarjani KG, Modarres M, Nazari H. Therapeutic Effect of Bevacizumab Injected

Into the Silicone Oil in Eyes with Neovascular Glaucoma after Vitrectomy for Advanced Diabetic Retinopathy. Eye 2010; 24, 717-719. [Medline]

54. Falavarjani KG, Hashemi M, Modarres M, Sanjari MS, Darvish N, Gordiz A.

Topography-guided vs Wavefront-optimized Surface Ablation for Myopia Using the WaveLight Platoform: A Contralateral Eye Study. Refractive surgery 2011;27(1):13-17. [Medline]

55. Falavarjani KG, Hashemi M, Joshaghani M, Azadi P, Ghaempanah MJ, Aghai GH.

Determining corneal power using Pentacam after myopic photorefractive keratectomy. Clinical and Experimental Ophthalmology 2010; 38: 341-345. [Medline]

56. Kashkouli MB, Pakdel F, Amani A, Asefi M, Aghai GH, Falavarjani KG. A Modified

Schirmer Test in Dry Eye and Normal Subjects: Open Versus Closed Eye and 1-Minute Versus 5-Minute Tests. Cornea 2010;29:384-387. [Medline]

57. Falavarjani KG, Modarres M, Nikeghbali A. Cataract and OCT. Ophthalmology

2010;117(4):849. [Medline]

58. Naseripour M, Falavarjani KG, Akbarzadeh S. Retinocytoma associated with bilateral retinoblastoma. Ind ian J Ophthalmol. 2010;58:155-156. [Medline]

59. Falavarjani KG. A Highly Specific Biomarker for Early Diagnosis and Treatment of

Neovascular Age-Related Macular Degeneration. J Ophthalmic Vis Res 2010; 5:71. [Pubmed]

60. Nikeghbali A, Falavarjani KG. Scleral Fixation of Dislocated Intraocular Lenses by

Haptic Externalization through a Clear Corneal Incision. J Ophthalmic Vis Res 2009; 4 (4): 266-269. [Pubmed]

61. Falavarjani KG, Modarres M, Joshaghani M, Azadi P, Hodjat P, Afshar AE.

Interocular differences of the Pentacam measurements in normal subjects. Clinical exp optom 2010; 93: 1: 26-30. [Medline]

62. Parvaresh MM, Modarres M, Falavarjani KG, Sadeghi K, Hammami P. Transscleral

diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity. JAAPOS 2009;13(6):535-538. [Medline]

63. Falavarjani KG, Sanjari MS, Modarres M, Aghamohammadi F. Axial length and

refractive error in NAION. Journal of optometry 2009;80:639-641. [Pubmed]

64. Falavarjani KG, Sanjari MS, Modarres M, Aghamohammadi F. Clinical profile of

patients with nonarteritic anterior ischemic optic neuropathy in an Iranian neuro-ophthalmology referral center from 2003 to 2008. Arch of Iranian Medicine 2009; 12(5):472 - 477. [Medline]

65. Naseripour M, Falavarjani KG, Bakhtiari P, Vosough P, Aryan F. Retinoblastom survival in Iran: 10 years experience of a referral center. Iranian J Ophthalmol 2009;21(4):17-24[Scopus] 66. Naseripour M, Falavarjani KG, Oladi MR, Modarres M. Testing Toxicity of

Intravitreal Bevacizumab (Avastin) used for the Treatment of Choroidal Neovascularization Associated with Age-Related Macular Degeneration: A Full Field ERG Study. Iranian J Ophthalmol 2009;21(3):49-55. [Scopus]

67. Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic

Macular Edema Following Panretinal Photocoagulation. Arch Ophthalmol 2010;128:262. [Medline]

68. Falavarjani KG. Implantable Posterior Segment Drug Delivery Devices; Novel Alternatives to Currently Available Treatments. JOVR 2009; 3: 192-4. [Pubmed]

69. Falavarjani KG, Modarres M. Intravenous Tissue Plasminogen Activator in Central

Retinal Artery Occlusion. Am J Ophthalmol 2009;147:1105. [Medline] 70. Modarres M, Nazari H, Falavarjani KG, Naseripour M, Parvaresh MM, Hashemi M.

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 2009; 19: 848-52. [Medline]

71. Falavarjani KG. Gene Therapy for Inherited Retinal Disorders. JOVR 2009; 2:66-7. [Pubmed]

72. Falavarjani KG, Modarres M. Bevacizumab Tachyphylaxis. Ophthalmology

2009;116:1016-1017. [Medline]

73. Kashkouli, MB, Aghai GH, Falavarjani KG, Astaraki A, Mirzajani H, AghaMohammadi F. Modified Schirmer's Test in Normal Eyes: Open versus Closed Eyes and 1-minute versus 5-minute Tests. Iranian J Ophthalmol 2009;21(1):52-56. [Scopus]

74. Modarres M, Naseripour M, Falavarjani KG. Intravitreal Injection of 2.5 mg VS 1.25

mg Bevacizumab (Avastin) for Treatment of CNV Associated with AMD. Retina 2009;29:319-324. [Medline]

75. Sanjari MS, Falavarjani KG, Mehrabani M, Ghiasian L, Zamani B. Retrobulbar

hemodynamics and carotid wall thickness in patients with nonarteritic anterior ischemic optic neuropathy. Br J Ophthalmol 2009;93;638-640. [Medline]

76. Sanjari MS, Falavarjani KG, Kashkouli MB, Aghai GH, Nojomi M, Rostami H.

Botulinum toxin-A injection with and without electromyographic assistance for treatment of sixth cranial nerve palsy: a pilot study. J AAPOS 2008;12(3):259-62. [Medline]

77. Nikeghbali A, Falavarjani KG. Modified transscleral fixation technique for refixation

of dislocated intraocular lenses. J Cataract Refract Surg 2008; 34:743-748. [Medline]

78. Asadi R, Falavarjani KG. Anterior and nasal transposition of the inferior oblique muscle

in patients with inferior oblique muscle overaction. Iranian J Ophthalmol 2008;20(2):41-45. [Scopus]

79. Kashkouli, MB, Khalatbari MR, Falavarjani KG, Ghaleanovi H, Sanjari MS, Zaman

B. Subarachnoid Hemorrhage Following Uneventful Thyroid Orbital Decompression. Ophthalm Plastic Recons Surg 2007;23:316-8. [Medline]

80. Nilforushan N, Falavarjani KG, Razeghinejad MR, Bakhtiari P. Cataract Surgery

for Congenital Cataract: Endothelial Cell Characteristics, Corneal Thickness and Impact on Intraocular Pressure. J AAPOS 2007;11:159-161. [Medline]

81. Modarres M, Sanjari MS, Falavarjani KG. Vitrectomy and Release of Presumed

Epipapillary Vitreous Traction for Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy Associated with Partial Posterior Vitreous Detachment. Ophthalmology 2007;114:340-344. [Medline]

82. Nikeghbali A, Falavarjani KG, Kheirkhah A, Bakhtiari P, Kashkouli MB. Pupil

Dilation with Intracameral Lidocaine during Phacoemulsification. J Cataract Refract Surg 2007; 33:101-103. [Medline]

83. Asadi R, Falavarjani KG. Anteriorization of Inferior Oblique Muscle and Downward

Transposition of Medial Rectus Muscle for Lost Inferior Rectus Muscle. J AAPOS 2006;10:592-593. [Medline]

84. Sanjari MS, Falavarjani KG, Kashkouli MB. Bilateral Peripapillary Staphyloma, A

Clinicoradiologic Report. Br J Ophthalmol 2006;90;1326-1327. [Medline]

85. Sanjari MS, Falavarjani KG, Parvaresh MM, Kharazi HH and Kashkouli MB. Bilateral aplasia of the optic nerve, chiasm, and tracts in an otherwise healthy infant. Br J Ophthalmol 2006;90;513-514. [Medline]

86. Soltan Sanjari M, Falavarjani KG, Parvaresh MM, Modarreszadeh M, Naseripour M,

Hashemi M, Nojomi M. Vitreopapillary traction in non-arteritic anterior ischemic optic neuropathy. Iranian J Ophthalmic Res. 2006.1(2).110-112. [Pubmed]

87. Nikeghbali A, Falavarjani KG, Kheirkhah A. Pupil Dilation with Intracameral

Lidocaine During Phacoemulsification; Benefits for the Patient and Surgeon. Indian Journal of Ophthalmology 2008;56:63-4. [Medline]

88. Asadi R, Falavarjani KG. Results of amblyopia therapy in unilateral organic ocular

abnormalities. Iranian J Ophthalmol 2008;20(3):24-27. [Scopus]

89. Asadi R, Falavarjani KG, Sadighi N. Orthoptic Treatment in the Management of Intermittent Exotropia. Iranian J Ophthalmol 2009;21(1):35-40. [Scopus]

90. Kashkouli, MB, Parvaresh MM, Mirzajani H, Astaraki A, Falavarjani KG, Ahadian

A. Intraoperative Mitomycin C Use During Filtration Surgery and Lacrimal Drainage System Obstruction. Am J Ophthalmol 2009;147:453-457. [Medline]

91. Sanjari MS, Parvaresh MM, Maleki A, Falavarjani KG, Pejman Bakhtiari.

Correlation between Retinal Nerve Fiber Layer Thickness by Optical Coherence Tomography and Perimetric Parameters in Optic Atrophy. J Ophthalmic Vis Res 2008;3:91-94. [Pubmed]

92. Modarres M, Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Parvaresh

MM. Two different doses of intravitreal bevacizumab for treatment of choroidal neovascularization associated with age related macular degeneration. J Ophthalmic Vis Res 2008;3:102-107. [Pubmed]

93. Falavarjani KG, Hashemi M, Modarres M, Nilforushan N. Corneal power

measurements with Pentacam after keratorefractive surgery. J Cataract Refract Surg 2009;35:612. [Medline]

94. Falavarjani KG, Modarres M, Foroutan AR, Bakhtiari P. Fibrin glue-assisted sutureless scleral fixation. J Cataract Refract Surg 2009;35:795. [Medline]

95. Parvaresh MM, Ghiasian L, Falavarjani KG, Soltan-Sanjari M, Sadighi N. Normal

Values of Standard Full Field Electroretinography in an Iranian Population. J Ophthalmic Vis Res 2009; 4 (2): 97-101. [Pubmed]

B. Farsi publications:

1. Hashemi M, Falavarjani KG, et al. Challenges in vitreoretinal surgery. Farsi book. 2011. Tehran, Iran.

2. Joshaghani M, Forootan A, Ghasemi H, Falavarjani KG, Madarshahi H, Nikbakht B. Evaluation of the efficacy of scar revision at graft-recipient junction for reduction of astigmatism incidence following penetrating keratoplasty. Daneshvar, 2010;17:1-7.

3. Falavarjani KG. Glaucoma diagnosis and screening. Family physicians empowerment training program (digital release). 2011. VHDI Inc.

4. Nilforushan N, Parvaresh MM, Amidirad D, Modarres-Zadeh M, Hashemi M, Falavarjani KG, Ahadian A. Trans-Scleral Diode Laser Cyclophotocoagulation for Management of Elevated Intraocular Pressure after Pars-Plana Vitrectomy. Bina J Ophthalmol 2010; 15: ٢٩٧-٢٨٩ . [www.sid.ir]

5. Modarres M, Nazari, Kanavi MR, Falavarjani KG, Ghasempour A. Evaluation of the safe doses of bevacizumab in rabbit eyes. Bina J Ophthalmol 2010; 15: 186-192. [www.sid.ir]

6. Falavarjani KG, Parvaresh MM, Sanjari MS, Modarres M, Aghamohammadi F, Ghasempour A. Evaluation of sclera canal diameters using OCT in patients with NAION. Laser in medicine 2009;3:19-22. [www.sid.ir]

7. Falavarjani KG, Hashemi M. How to encounter the computer related ocular problems. Farsi book. 2009. Tehran, Iran.

8. Falavarjani KG, Modarres, Hodjat P, Afshar AE, Ghasempour A. Laser in diabetic retinopathy. Laser in medicine 2009;1:36-44. [www.sid.ir]

9. Falavarjani KG, Hashemi M, Parvaresh MM, Modarres M, Sanjari MS, Afshar AE. Study of the knowledge and attitude of computer users about the computer related eye problems. Bina J Ophthalmol 2010; 15 (2): 121-127. [www.sid.ir]

10. Falavarjani KG, Sanjari MS, Modarres M, Mehrabani M, Rohani M,

Aghamohammadi F. Ophthalmic artery flow velocity in patients with acute unilateral nonarteritic anterior ischemic optic neuropathy. Bina J Ophthalmol 2009;15:3-7. [www.sid.ir]

11. Mohammadreza H, Hejazi SM, Oghabian MA, Ahmadian AR, Naseripour M,

Zarrin M, Falavarjani KG, Nazari H. Measurement of the area of CNV secondary to AMD using a modified threshold method. Iranian Journal of Biophysics. 2008; 5:77-84.

12. Hashemi M, Falavarjani KG. Vitrectomy for Complications of Branch Retinal Vein

Occlusion. Bina J Ophthalmol 2009; 14 (4): 378-383. [www.sid.ir] 13. Falavarjani KG, Mehrabani M, Ghiasian L, Sanjari MS, Zamani B, Oladi MR,

Modarres M. Carotid wall thickness in patients with acute unilateral nonarteritic anterior ischemic optic neuropathy. Bina J Ophthalmol; 14:121-124. [www.sid.ir]

14. Naseripour M, Falavarjani KG, Mirfallah K, Bagheri R. Photodynamic therapy for

vasoproliferative tumors and capillary hemangiomas of the retina. Bina J Ophthalmol 2009;14:109-115. [www.sid.ir]

15. Parvaresh MM, Falavarjani KG. Butterfly-Shaped Macular Dystrophy. Bina J

Ophthalmol 2006;12(1):101-104. [www.sid.ir]

16. Sanjari MS, Shokrollahi S, Falavarjani KG. Refractive and corneal topographic changes after hang-back strabismus surgery. Medical journal of Iran university of medical sciences 2010;68:49-55.

17. Nikeghbali A, Falavarjani KG, Modarreszadeh M, Hashemi M, Parvaresh MM,

Naseripour M. longterm results of scleral fixation. Medical journal of Iran university of medical sciences 2009:63:169-175.

18. Hashemi M, Akbarzadeh S, Falavarjani KG. Outcomes of heavy silicon oil tamponade in

complicated retinal detachment surgery. Bina J Ophthalmol 2008;13:418-423.

19. Modarres M, Falavarjani KG, Salehian M, Seddigh N, Sanjari MS. Evaluation of the prevalence of systemic disease in patients with anterior ischemic optic neuropathy in Rassoul Akram hospital. Medical journal of Iran university of medical sciences 2009;63:126-132.

20. Hashemi M, Falavarjani KG, Navahi RA, Mirfallah K, Bakhtiari P. Comparison of the

results of intravitreal injection of triamcinolone acetonide and bevacizumab (Avastin) in patients with clinically significant macular edema unresponsive to standard treatment. Medical journal of Iran university of medical sciences 2009;63:201-208.

21. Falavarjani KG, Hashemi M. Principles of modern laser refractive surgery. Markazi eye

clinic, Tehran. 2007. (Farsi book)

22. Falavarjani KG, Bayanati sh, Vaghari B. Rheumatologic and immune system diseases. In: Harrison`s Principles of Internal Medicine. 16th ed. Samat, Tehran. 2005. (Farsi translation). [www.nlai.ir]

23. Falavarjani KG, Maylie B. Weekly epidemiological record 1997. World Health

Organization magazine. (Digital network database, Farsi translation as final thesis)

PRESENTATIONS AT SCIENTIFIC MEETINGS

1. Effect of optical coherence tomography image quality on macular thickness measurements and error rate. Euretina. Nice, France. Sep 2015. (Free paper)

2. Update on postop CME. Farabi Annual Meeting. May 2015. Tehran, Iran. (Lecture)

3. Management of complications after intravitreal injections. Farabi Annual Meeting. May 2015. Tehran, Iran. (Lecture)

4. Management of diabetic retinopathy. Annual Meeting of the Iranian Vitreoretinal Society and Isfahan Eye Department Annual Meeting. April 2015. Isfahan, Iran. (Panel member)

5. OCT Artifacts and The Graphs in OCT Reports That We Do Not Care Them. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Lecture)

6. Scleral Buckling Surgery for Rhegmatogenous Retinal Detachment with Subretinal Proliferation. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Free paper)

7. Effect of Grid Decentration on Macular Thickness Measurements in Normal Subjects and Patients with Diabetic Macular Edema. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Free paper)

8. Electronic Patients Recording and Tele-ophthalmology: Future of Ophthalmology. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Moderator)

9. 2014 Young Ophthalmologist Program, Retina Session. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Moderator)

10. Intra-silicone oil injection of methotrexate at the end of retinal reattachment

surgery for severe proliferative vitreoretinopathy. Euretina. London, UK. Sep 2014. (Free paper)

11. Intra-silicone Oil Injection Of Methotrexate At The End Of Vitrectomy For

Retinal Detachment Associated With Severe Proliferative Diabetic Retinopathy. Euretina. London, UK. Sep 2014. (Free paper)

12. Controversies in the management of vitreomacular interface disorders. IUMS Eye Research Center Annual Meeting. Tehran, Iran. July 2014. (Moderator)

13. Update on CSCR. Annual Meeting of the Iranian Vitreoretinal Society and Tabriz Eye Department Annual Meeting. June 2014. Tabriz, Iran. (Lecture)

14. Management of Anti-VEGF non-responders. Farabi Annual Meeting. April 2014. Tehran, Iran. (Lecture)

15. The 4th annual congress of Iranian research association for vision and ophthalmology (IRAVO ). Feb 2014. Razi Convention Center, Tehran, Iran. (Chair)

16. Peripapillary Nerve Fiber Layer Thickness Changes after Macular Photocoagulation for Clinically Significant Diabetic Macular Edema. The 4th annual congress of IRAVO. Feb 2014. Razi Convention Center, Tehran, Iran. (Free paper)

17. Diagnosis and treatment of CSCR. Shahid Beheshti annual ophthalmology seminar. Jan 2014. Razi Convention Center, Tehran, Iran.

18. Treatment of dry AMD, an update. One day symposium. Farabi Eye Hospital. Jan 2014. Tehran, Iran. (Lecture)

19. Approach to Common Macular Disorders (Symposium). 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Moderator)

20. Approach to CSCR. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct

2013. (Lecture)

21. Ultrasonography in Vitreoretinal Diseases (Workshop). 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Moderator)

22. Basic Ultrasonography Examination Techniques. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Lecture)

23. Case Presentation and OCT Interpretation. 23rd Iranian congress of

ophthalmology. Tehran, Iran. Oct 2013. (Panel Discussion)

24. Peripapillary Nerve Fiber Layer Thickness Changes after Macular Photocoagulation for Clinically Significant Diabetic Macular Edema. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

25. Optical Coherence Tomography Grid Decentration after Manual Overlay Adjustment and Its Effect on Macular Thickness Measurements. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

26. Dry Eye after Microincision and Conventional Vitrectomy. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

27. Intra-silicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

28. Intra-silicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy. Euretina. Hamburg, Germany. Sep 2013. (Free paper)

29. Controversies in the cataract surgery in macular disorders. IUMS Eye Research Center Annual Meeting. Tehran, Iran. July 2013. (Moderator)

30. Approach to CSR. Annual Meeting of the Iranian Vitreoretinal Society and Farabi Annual Meeting. Tehran, Iran. Apr. 2013. (Lecture)

31. How to retrieve educational materials on AAO website. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

32. Ranibizumab for Edema of the mAcula in Diabetes (READ -2 study). 22th

Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

33. General ocular and systemic complications of intraocular injection of anti-VEGF agents. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

34. Incidence of acute endophthalmitis after intravitrealbevacizumab injection in a single clinical center. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Presentation)

35. FA, ICG, and OCT Case Presentations. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

36. Anti VEGF Therapy Vs Combined PDT and Anti VEGF Therapy for Neovascular Age-Related Macular Degeneration. WOC. Abudhabi, UAE. Feb 2012. (Lecture)

37. Parsplana vitrectomy and Intravitreal phacoemulsification for removal of the dropped nucleus. WOC. Abudhabi, UAE. Feb 2012. (Free paper)

38. Vitrectomy for posterior segment intraocular foreign bodies; visual and anatomical outcomes. WOC. Abudhabi, UAE. Feb 2012. (Free paper)

39. Interactive session on uveitis. WOC. Abudhabi, UAE. Feb 2012. (Lecture)

40. ROP treatment and follow up. One day Pediatric Retina seminar. Labbafinejad Medical Center. Tehran, Iran. Dec 2011. (Lecture)

41. Basic techniques for B scan ultrasonography. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

42. Ultrasonography for fundus mass. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

43. Surgical treatment for submacular hemorrhage. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

44. Guide line for retinal break. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

45. Intravitreal injection of bevacizumab for severe ROP. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Free paper)

46. Determination of the exact crossing point of the corneal thickness spatial profile line and the normal progression line in keratoconus and normal eyes using specially designed software. ESCRS. Vienna, Austria. Sep 2011(Free paper)

47. Longterm complications following Ru-106 plaque radiotherapy for uveal melanoma.

20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper) 48. Evaluation of scleral canal diameters at optic nerve head using OCT in patients with

NAION. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper)

49. Biphasic pattern of response to intravitreal erythropoietin injection for treatment of

nonarteritic anterior ischemic optic neuropathy (NAION). 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper)

50. Intraoperative use of mitomycin C during vitrectomy for prevention of PVR recurrence in post vitrectomy eyes with RRD complicated by severe PVR. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper)

51. What does clinical trials tell us about treatment of BRVO? 20th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2010. (Lecture)

52. Ultrasonographic screening of the fundus. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Lecture)

53. Ultrasonographic evaluation of the fundus mass. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Lecture)

54. Basics of IOL calculation. 13th Iranian congress of optometry. Tehran, Iran,

September 2010. (Lecture)

55. Nutritional supplements for preventing AMD. 4th seminar of IUMS eye department, Tehran, Iran, August 2010. (Lecture)

56. Neuroprotection in optic neuropathies. 3rd congress of vitreoretinal society, Shiraz, Iran, June 2010. (Lecture)

57. Full field ERG deficits in wet AMD. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

58. Erythropoietin for the treatment of NAION. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

59. Brachytherapy for uveal malignant melanoma in terms of visual function. 19th Iranian

congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

60. Sandwitch therapy for the treatment of uveal malignant melanoma. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

61. A modified shirmer test in normal subjects and dry eye: open versus closed eyes and i-minute versus 5-minute test. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

62. Transscleral diod laser photocoagulation for the treatment of type one ROP. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

63. Ocular Emergencies. 12th Iranian congress of optometry. Tehran, Iran, August 2009. (Lecture)

64. Pentacam workshop. Pentacam one day workshop. Rassoul Akram Hospital,

Tehran, Iran, July 2009. (Moderator)

65. Pentacam maps. Pentacam one day workshop. Rassoul Akram Hospital, Tehran, Iran, July 2009. (Lecture)

66. Ocular side effects of systemic drugs. Pharmacotherapy in ophthalmology. Three-day

symposium. Tehran, Iran, Apr 2009. (Lecture) 67. Corticosteroids in uveitis. Pharmacotherapy in ophthalmology. Three-day symposium.

Tehran, Iran, Apr 2009. (Lecture) 68. Pentacam keypoints. Medical college, Iran university of medical sciences. One-day

optometry symposium. Tehran, Iran, Nov 2008. (Lecture) 69. OCT; 40 pictures, 40 explanations. Medical college, Iran university of medical

sciences. One-day optometry symposium. Tehran, Iran, Nov 2008. (Lecture) 70. Biometry accuracy. Medical college, Iran university of medical sciences. One-day

optometry symposium. Tehran, Iran, Nov 2008. (Lecture) 71. Ophthalmic Nursing workshop. 18th Iranian congress of ophthalmology. Tehran,

Iran. Nov 2008. (Moderator 72. Therapeutic Effect of Bevacizumab Injected Into the Silicon Oil in Eyes With Rubeotic

Glaucoma After Vitrectomy for Proliferative Diabetic Retinopathy. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

73. Ruthenium brachytherapy for retinoblastoma. 18th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 74. Primary Transpupillary Thermotherapy for Small Choridal Melanoma. 18th Iranian

congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 75. Combined phacoemulsification, intraocular lens implantation and parsplana vitrectomy

in advanced diabetic retinopathy. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

76. Transscleral diode laser photocoagulation in the treatment of threshold retinopathy of

prematurity. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

77. Standardized full field electroretinography: normal values and variation with age. 18th

Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 78. Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization associated

with age related macular degeneration: a full field ERG study. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

79. Photodynamic therapy in retinal angiomatosis proliferations. 18th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 80. Review of congenital disinnervation syndromes. 18th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 81. Effects of homatropine on pain control and relief in patients undergoing photorefractive

keratectomy surgery. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

82. Therapeutic Effect of Bevacizumab Injected Into the Silicon Oil in Eyes With Rubeotic

Glaucoma After Vitrectomy for Proliferative Diabetic Retinopathy. Annual Meeting of the American Academy of Ophthalmology. New Orleans, USA. Nov 2008. (Poster presentation)

83. Clinical anatomy of the eye. Two-day symposium for general physicians. Tehran, Iran,

October 2008. (Lecture) 84. The eye in hypertension. 11th Iranian congress of optometry. Tehran, Iran, August

2008. (Lecture) 85. Pentacam. Rassoul Akram Hospital, One-day symposium. Tehran, Iran, July 2008.

(Lecture) 86. Orbscan. Rassoul Akram Hospital, One-day symposium. Tehran, Iran, July 2008.

(Lecture) 87. Orbscan VS Pentacam. Rassoul Akram Hospital, One-day symposium. Tehran, Iran,

January 2008. (Lecture) 88. Custom ablation. Rassoul Akram Hospital, One-day symposium. Tehran, Iran, January

2008. (Lecture) 89. Study design. Rassoul Akram Hospital, One-day symposium. Tehran, Iran, January

2008. (Lecture) 90. Refixation of Dislocated Intraocular Lens: A Modified Surgical Technique. 17th

Iranian congress of ophthalmology. Tehran, Iran. Dec 2007. (Free paper) 91. Intravitreal Injection of 2.5mg vs. 1.25mg Bevacizumab for Treatment of CNV

Associated With AMD. Annual Meeting of the American Academy of Ophthalmology. New Orleans, USA. Nov 2007. (Poster presentation)

92. Vitreopapillary Traction in Nonarteritic Anterior Ischemic Optic Neuropathy (NAION).

Middle East African council of ophthalmology. UAE, Dubai. April-March 2007. (Free paper)

93. Intravitreal Injection of Bevacizumab for Treatment of Macular Edema after Retinal

Vein Occlusion. Middle East African council of ophthalmology. UAE, Dubai. April-March 2007. (Free paper)

94. Complications associated with Intravitreal injection of Bevacizumab. Middle East

African council of ophthalmology. UAE, Dubai. April-March 2007. (Free paper)

95. OCT findings in Vitreoretinal Interface Abnormalities. OCT News course, Central Eye

Clinic , Tehran, Iran. Jan 2007. (Oral lecture) 96. Release of vitreopapillary traction as a management of non arteritic anterior ischemic

optic neuropathy. 14th Iranian congress of ophthalmology, Tehran, Iran. Dec 2004. (Free paper)

97. Vitreopapillary traction as a cause of non-arteritic anterior ischemic optic neuropathy.

15th Iranian congress of ophthalmology, Tehran, Iran. Dec 2005. (Free paper) 98. Indocyanine green angiography. Interactive course of retina and vitreous, Iran

University of Medical Sciences. Tehran, Iran. Aug 2006. (Lecture) 99. Intravitreal bevacizumab for the treatment of choroidal neovascularization. 16th

Iranian congress of ophthalmology, Tehran, Iran. Nov 2006. (Free paper) 100. Vitrectomy and release of presumed epipapillary vitreous traction for treatment of Nonarteritic anterior ischemic optic neuropathy. European neuro-ophthalmology society, 7th meeting, Moscow, Russia. June 2005. (Poster presentation) 101. Vitreopapillary Traction in Non-Arteritic Anterior Ischemic Optic Neuropathy

(NAION). International neuro-ophthalmology society meeting, Tokyo, Japan. Nov 2006. (Poster presentation)

102. Pupil Dilation with Intracameral Lidocaine during Phacoemulsification. Joint

Meeting of the American Academy of Ophthalmology and the Asia Pacific Academy of Ophthalmology (APAO). Las Vegas, Nevada, USA. Nov 2006. (Poster presentation)

COURSES ATTENDED

1. Research Methodology. One-day symposium, Rassoul Akram Hospital. Tehran, Iran, August 2015.

2. Advance workshop of question designation. One-day symposium, Ministry of Health, Tehran, Iran, July 2015.

3. Strategy Planning. One-day symposium, Medical College, IUMS, Tehran, Iran. June 2014.

4. Pediatric retina. One-day symposium, Labbafinejad Hospital. Tehran, Iran, December

2011.

5. Retinal vascular disorders. One-day symposium, Farabi Hospital. Tehran, Iran, Oct 2011.

6. Presbyopia correction. One-day symposium, Rassoul Akram Hospital. Tehran, Iran,

December 2010.

7. Ocular trauma. One-day symposium, Imam Hossein Hospital. Tehran, Iran, Aug 2010. 8. Medical education. 3 days conference. Razi center, Tehran, Iran, June 2010.

9. Visual field. Rassoul Akram Hospital, One-day symposium. Tehran, Iran, October 2009. 10. New methods for question design. Rassoul Akram Hospital, One-day symposium. Tehran,

Iran, March 2009

11. Advanced cataract surgery technology. Alcon two-day symposium. Catania, Italy. June 2008.

12. Contemporary Management of Common Vitreoretinal Disorders. American Academy

of Ophthalmology's Symposium. Dubai, March 2007. 13. Diagnostic ophthalmology instruments. Three-day symposium. Iran University of

Medical Sciences. Tehran, Iran. July 2007. 14. Clinical Conference for surgical treatments of glaucoma. Rassoul Akram Hospital, One-

day symposium. Tehran, Iran, February 2007. 15. Clinical Conference for keratoconus. Rassoul Akram Hospital, One-day symposium.

Tehran, Iran, January 2007. 16. Surgical Facial Rejuvenation. Rassoul Akram Hospital, One-day symposium. Tehran,

Iran, February 2006. 17. Orbital CT Scan and MRI, Basics and practical interpretation. Iran University of

Medical Sciences. Tehran, Iran, January 2004. 18. One week course of Research and Statistics. Held by Iran University of Medical

Sciences. Tehran, Iran, September 2003. 19. Cosmetic Facial Botulinum Toxin Injections. One day workshop held by IPSEN

company for the ophthalmologists. Rassoul Akram Hospital Tehran, Iran, September 2006.

20. Non-Surgical Facial Rejuvenation. Rassoul Akram Hospital, One-day symposium, Tehran, Iran, October 2005.

21. Clinical Conference for Optic Neuropathy. Rassoul Akram Hospital, One-day

symposium. Tehran, Iran, March 2006.

22. OCT News. Central Eye Clinic. One-day symposium. Tehran, Iran. January 2007. 23. Evidence based medicine. Rassoul Akram Hospital, One-day symposium. Tehran, Iran,

MEMBERSHIP

REFERENCES

May 2006. 24. Interactive course of retina and vitreous. Three-day symposium. Iran University of

Medical Sciences. Tehran, Iran. Aug 2006.

25. Medical methodology and evidence based medicine. Three days workshop. Medical faculty. Iran University of Medical Sciences. Tehran, Iran. November 2003.

1. Iran National Elites Foundation 2. European Society of Retina Specialists (Euretina) 3. Middle East African Council of Ophthalmology (MEACO) 4. Iranian Vitreoretinal Society 5. Iranian Society of Ophthalmology (IrSO) 6. Iran Medical Council

1. Mehdi Modaress, MD, Professor in Clinical Ophthalmology and Vitreoretinal surgery. Iran University of Medical Sciences.

Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162 Mmodarress51@yahoo.com

2. Mohsen Bahmani Kashkouli, MD, Professor in Clinical Ophthalmology and Ophthamic Plastic Surgery. Iran University of Medical Sciences.

Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162 bahmanik@yahoo.com

3. Mohammad Mehdi Parvaresh, MD, Professor in Clinical Ophthalmology and Vitreoretinal surgery. Iran University of Medical Sciences.

Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162 mmparvaresh@yahoo.com

4. Masood Naseripour, MD, Professor in Clinical Ophthalmology and Ocular Oncology. Iran University of Medical Sciences.

Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162 masoodnp@yahoo.com